The Black Swan Analysis team are delighted to announce that their Senior Analyst, Christopher Bell, has been awarded the highly respected ‘Ian Burgess Award’ at the Annual British Healthcare Business...
Coeliac disease is a genetic condition which can affect anybody, irrespective of age or gender; nevertheless there is a strong relationship between gender and people diagnosed with the disease, as...
Prostate cancer is one of the most common male cancers in the developed world. The most significant risk factor for prostate cancer is age. It is very uncommon below the age of 45 however around...
Two recent healthcare events supported by the One Nucleus biotech network, has nicely highlighted some of the challenges facing healthcare companies and investors that are looking to bring...
It’s Prostate Cancer Awareness Month this month, one of the most common male cancers in the developed world. Prevalence rates vary widely across the globe. It is least common in South and East Asia,...
BioTrinity is Europe’s leading investment and bio-partnering conference and provides a unique platform for companies across the life sciences industry to achieve their business objectives, secure...
Coronary heart disease (CHD) is the leading cause of death both in the UK and worldwide. CHD generally affects more men than women, but both are at higher risk as age increases. The disease occurs...
Two big things struck me as interesting during an Innovations in Oncology Conference in Edinburgh this month. Firstly how exciting the market is right now, with many productive collaborations...
There’s no common worldwide definition of what constitutes a rare disease. The European Commission on Public Health defines rare diseases as "life-threatening or chronically debilitating diseases...
Fabry disease is caused by a mutation in the alpha-galactosidase-A gene (GLA). This gene codes for an enzyme active in lysosomes, the recycling centres within cells. Lysosomes contain more than 50...
